Search Results - "ANDERA, L"

Refine Results
  1. 1

    The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies by Zivny, J, Klener, Jr, P, Pytlik, R, Andera, L

    Published in Current pharmaceutical design (01-01-2010)
    “…Apoptosis is a normal aspect of human physiology ensuring tissue homeostasis. Evasion of endogenous cell death processes, including apoptosis, represents one…”
    Get more information
    Journal Article
  2. 2

    Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo by OIKONOMOU, E, KOTHONIDIS, K, ZOGRAFOS, G, NASIOULAS, G, ANDERA, L, PINTZAS, A

    Published in British journal of cancer (02-07-2007)
    “…Most data on the therapeutic potential of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as well as resistance to FAS ligand (FASL) in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling by Kaminskyy, V O, Surova, O V, Piskunova, T, Zborovskaya, I B, Tchevkina, E M, Andera, L, Zhivotovsky, B

    Published in Cell death & disease (07-03-2013)
    “…TNF-related apoptosis-inducing ligand (TRAIL) is a promising cytokine for killing tumor cells. However, a number of studies have demonstrated that different…”
    Get full text
    Journal Article
  5. 5

    TRAIL (Apo2l) suppresses growth of primary human leukemia and myelodysplasia progenitors by PLASILOVA, M, ZIVNY, J, JELINEK, J, NEUWIRTOVA, R, CERMAK, J, NECAS, E, ANDERA, L, STOPKA, T

    Published in Leukemia (2002)
    “…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, APO2L) has been shown to induce apoptosis in a number of tumor cell lines as well as in some…”
    Get full text
    Journal Article
  6. 6

    α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells by TOMASETTI, M, RIPPO, M. R, ALLEVA, R, MORETTI, S, ANDERA, L, NEUZIL, J, PROCOPIO, A

    Published in British journal of cancer (19-04-2004)
    “…Malignant mesothelioma (MM) is a fatal type of neoplasia with poor therapeutic prognosis, largely due to resistance to apoptosis. We investigated the apoptotic…”
    Get full text
    Journal Article
  7. 7

    Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL) by Leahomschi, S, Molinsky, J, Klanova, M, Andera, L, Peterka, M, Gasova, Z, Klener, Sr, P, Trneny, M, Necas, E, Simonova, T, Zivny, J, Klener, Jr, P

    Published in Neoplasma (01-01-2013)
    “…Disruption of apoptotic pathways belongs to commonly reported molecular mechanisms that underlie cancer drug resistance. Tumor necrosis factor (TNF)-related…”
    Get more information
    Journal Article
  8. 8

    Coenzyme Q blocks biochemical but not receptor‐mediated apoptosis by increasing mitochondrial antioxidant protection by Alleva, Renata, Tomasetti, Marco, Andera, Ladislav, Gellert, Nina, Borghi, Battista, Weber, Christian, Murphy, Michael P., Neuzil, Jiri

    Published in FEBS letters (10-08-2001)
    “…Generation of free radicals is often associated with the induction and progression of apoptosis. Therefore, antioxidants can prove anti‐apoptotic, and can help…”
    Get full text
    Journal Article
  9. 9

    Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity by Neuzil, J, Kågedal, K, Andera, L, Weber, C, Brunk, U T

    Published in Apoptosis (London) (01-04-2002)
    “…The incidence of cancer and atherosclerosis, two most common causes of death in developed countries, has been stagnating or, even, increasing. Drugs effective…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Functional interactions between p53 and the TFIIH complex are affected by tumour‐associated mutations by Léveillard, T., Andera, L., Bissonnette, N., Schaeffer, L., Bracco, L., Egly, J. M., Wasylyk, B.

    Published in The EMBO journal (01-04-1996)
    “…The p53 tumour suppressor is mutated in the majority of human tumours. p53′s proposed role as the guardian of the genome is reflected in its multiple effects…”
    Get full text
    Journal Article
  12. 12

    Transcription abnormalities potentiate apoptosis of normal human fibroblasts by Andera, L, Wasylyk, B

    Published in Molecular medicine (Cambridge, Mass.) (01-12-1997)
    “…Apoptosis is a natural process by which damaged and potentially tumorigenic cells are removed. Induction of apoptosis is important in chemotherapy aimed at…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-γ-dependent way by Jostarndt, K, Rubic, T, Kuhn, H, Anthosen, M.W, Andera, L, Gellert, N, Trottman, M, Weber, Christian, Johansen, B, Hrboticky, N, Neuzil, J

    Published in Biochemical pharmacology (01-03-2004)
    “…Peroxisome proliferator-activated receptor-γ (PPARγ) has been suggested to upregulate CD36. Since free oxidized polyunsaturated fatty acids are PPARγ ligands,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Determinants of affinity and mode of DNA binding at the carboxy terminus of the bacteriophage SPO1-encoded type II DNA-binding protein, TF1 by ANDERA, L, GEIDUSCHEK, E. P

    Published in Journal of Bacteriology (01-03-1994)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  17. 17

    Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name? by Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, Dong, Lanfeng, Andera, Ladislav, Ralph, Stephen J.

    “…Recent evidence suggests that a subset of cells within a tumour have ‘stem-like’ characteristics. These tumour-initiating cells, distinct from non-malignant…”
    Get full text
    Journal Article
  18. 18

    Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence by Mrazkova, Blanka, Dzijak, Rastislav, Imrichova, Terezie, Kyjacova, Lenka, Barath, Peter, Dzubak, Petr, Holub, Dusan, Hajduch, Marian, Nahacka, Zuzana, Andera, Ladislav, Holicek, Petr, Vasicova, Pavla, Sapega, Olena, Bartek, Jiri, Hodny, Zdenek

    Published in Aging (Albany, NY.) (28-03-2018)
    “…Aging involves tissue accumulation of senescent cells (SC) whose elimination through senolytic approaches may evoke organismal rejuvenation. SC also contribute…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cell death signalling pathways in the pathogenesis and therapy of haematologic malignancies: overview of apoptotic pathways by Klener, Jr, P, Andera, L, Klener, P, Necas, E, Zivný, J

    Published in Folia biologica (2006)
    “…Apoptosis, a Greek descriptive term for falling leaves or petals, plays an important role in the progression of many diseases. Apoptosis is essential for the…”
    Get full text
    Journal Article